← Back to dashboard
Share
050%
Type 1 Diabetes Cure?
Investor summaryBullish
Eledon Pharma reports 100% insulin independence in T1D trial, signaling a potential major medical breakthrough.
Bull points
- Clinical data shows 100% of patients achieved insulin independence, indicating high efficacy.
- Potential for significant market revaluation if the treatment becomes a standard cure.
- Positive comparison to previous major pharmaceutical breakthroughs suggests strong investor interest.
Bear points
- Small sample size or early-stage data may not guarantee long-term success or FDA approval.
- Biotech stocks are highly volatile and sensitive to regulatory setbacks beyond initial trials.
- Commercial viability and pricing power remain uncertain despite clinical success.
Post body
100% of patients achieved insulin independence. Feel like this could be a major breakthrough in the medical field. Should get a standing ovation like that pancreatic cancer drug if true
https://ca.finance.yahoo.com/news/eledon-announces-updated-data-investigator-110000620.html
Discussion · top comments
No comment snapshot fetched for this post yet.

r/wallstreetbets